Cargando…
Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics
Cryptosporidiosis, caused by the apicomplexan parasite Cryptosporidium parvum, is a moderate-to-severe diarrheal disease now recognized as one of the leading causes of morbidity and mortality in livestock globally, and in humans living in resource-limited parts of the world, particularly those with...
Autores principales: | Riggs, Michael W., Schaefer, Deborah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120472/ https://www.ncbi.nlm.nih.gov/pubmed/31452167 http://dx.doi.org/10.1007/978-1-4939-9748-0_15 |
Ejemplares similares
-
Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model
por: Stebbins, Erin, et al.
Publicado: (2018) -
Impact of confinement housing on study end-points in the calf model of cryptosporidiosis
por: Graef, Geneva, et al.
Publicado: (2018) -
Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022) -
Control of cryptosporidiosis in neonatal calves: Use of halofuginone lactate in two different calf rearing systems
por: De Waele, V., et al.
Publicado: (2010) -
Cryptosporidiosis
Publicado: (2012)